Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
John V Heymach, David Harpole, Martin Reck
Topics & Concepts
MedicineDurvalumabPerioperativeCancerGeneral surgeryLung cancerSurgeryOncologyInternal medicineImmunotherapyNivolumabLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations